Clinical Trial Update: ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence [Phase 3]

View source ↗

Summary

Phase 3 results for VIVITROL (naltrexone) after enforced abstinence in alcohol dependence were posted in 2011, detailing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Alcohol Dependence | Phase 3 | Status: COMPLETED | Results posted: 2011-04-13